Sales Growth YoY (Last Twelve Months): Sagimet Biosciences Inc (SGMT)

Graphic logo of Sagimet Biosciences (SGMT)

Year-over-year sales volatility over a rolling 12-month period highlights the pressure from industry behemoths competing for leadership in the metabolic segment. The value of 0.00 is recorded as the baseline value. The business foundation of Sagimet Biosciences (SGMT) relies on partnerships with medical centers to accelerate steatohepatitis therapy, and its independence from macroeconomic factors makes the asset a resilient defensive tool.

Sales Growth YoY (Last Twelve Months): Sagimet (SGMT) for 11/23/2025 - 11/19/2026

Summary analytical data breakdowns for Sagimet Biosciences, Inc. (SGMT)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:SGMT (Sagimet)
Mass-produced product of Sagimet Biosciences Inc.

This indicator measures the daily percentage growth in revenue over a rolling 12-month period, allowing for the real-time tracking of business scaling rates outside of quarterly cycles. By analyzing the relative year-over-year (LTM) revenue dynamics, an investor can assess the commercial efficiency of Sagimet Biosciences (SGMT) drugs amidst intense patent disputes and verify the market success of their FDA-approved developments.

Who Sagimet Biosciences competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)